Concepedia

Andrew Looka

AL

Statistics

Publications

2

Citations

45

H-Index

2

Active since

2023

Affiliations

Dana-Farber Cancer Institute(Current)

Andrew Looka is an author at Dana-Farber Cancer Institute specializing in vaccine immunology, immunotherapy, and vaccinology.

ORCID

Publications per year

2023–2024

2

Publications

2

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma

Andrew Looka, David Qualls, Robert Redd et al. · Blood Advances · 2024 · 30 citations · Full text

, , +16

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients

Muneerah M Aleissa, Jessica S Little, Sonya Davey et al. · Transplantation and Cellular Therapy · 2023 · 15 citations · Full text

, , +17

1–2 of 2